Published this week in Cell Reports Medicine, the study reveals that the drug lurbinectedin, an approved second-line therapy for SCLC, activates the STING-IFN signaling pathway to enhance the ...

cGAS-STING Pathway: A signaling pathway activated by cytosolic DNA that leads to the production of type I interferons and plays a role in immune responses. Type I Interferons: A group of proteins ...